KLK2 and prostate adenocarcinoma: Prostate adenocarcinoma and urothelial bladder carcinoma exhibited significant up-regulation of KLK2 and KLK4 gene expressions (KLK2: 3-fold and 2-fold, KLK4: 3-fold and 2-fold).